|
Goodrx Holdings, Inc. (GDRX) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
GoodRx Holdings, Inc. (GDRX) Bundle
Améliorez vos stratégies d'investissement avec la calculatrice DCF (GDRX)! Utilisez des données financières GoodRX réelles, ajustez les prévisions et les dépenses de croissance et observez les effets immédiats de ces changements sur la valeur intrinsèque de (GDRX).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 550.7 | 745.4 | 766.6 | 750.3 | 792.3 | 874.9 | 966.0 | 1,066.7 | 1,177.8 | 1,300.5 |
| Revenue Growth, % | 0 | 35.36 | 2.83 | -2.12 | 5.61 | 10.42 | 10.42 | 10.42 | 10.42 | 10.42 |
| EBITDA | -257.1 | 48.0 | 68.5 | 108.8 | 153.9 | 4.6 | 5.1 | 5.6 | 6.2 | 6.8 |
| EBITDA, % | -46.69 | 6.44 | 8.94 | 14.5 | 19.43 | 0.52494 | 0.52494 | 0.52494 | 0.52494 | 0.52494 |
| Depreciation | 22.9 | 37.6 | 57.5 | 107.7 | 69.5 | 69.7 | 77.0 | 85.0 | 93.8 | 103.6 |
| Depreciation, % | 4.16 | 5.05 | 7.5 | 14.35 | 8.78 | 7.97 | 7.97 | 7.97 | 7.97 | 7.97 |
| EBIT | -280.0 | 10.4 | 11.0 | 1.2 | 84.4 | -65.1 | -71.9 | -79.4 | -87.7 | -96.8 |
| EBIT, % | -50.85 | 1.39 | 1.44 | 0.15408 | 10.65 | -7.44 | -7.44 | -7.44 | -7.44 | -7.44 |
| Total Cash | 968.7 | 941.1 | 757.2 | 672.3 | 448.3 | 778.6 | 859.7 | 949.3 | 1,048.2 | 1,157.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 68.7 | 126.4 | 117.1 | 160.0 | 160.8 | 151.1 | 166.8 | 184.2 | 203.4 | 224.6 |
| Account Receivables, % | 12.48 | 16.96 | 15.28 | 21.33 | 20.3 | 17.27 | 17.27 | 17.27 | 17.27 | 17.27 |
| Inventories | 2.9 | -8.3 | .0 | .0 | .0 | -1.0 | -1.1 | -1.3 | -1.4 | -1.5 |
| Inventories, % | 0.5266 | -1.12 | 0 | 0 | 0 | -0.1182 | -0.1182 | -0.1182 | -0.1182 | -0.1182 |
| Accounts Payable | 10.3 | 17.5 | 17.7 | 36.3 | 14.1 | 23.0 | 25.4 | 28.0 | 31.0 | 34.2 |
| Accounts Payable, % | 1.87 | 2.35 | 2.31 | 4.83 | 1.78 | 2.63 | 2.63 | 2.63 | 2.63 | 2.63 |
| Capital Expenditure | -35.8 | -34.5 | -55.2 | -55.8 | .0 | -45.1 | -49.8 | -55.0 | -60.7 | -67.0 |
| Capital Expenditure, % | -6.51 | -4.62 | -7.2 | -7.43 | 0 | -5.15 | -5.15 | -5.15 | -5.15 | -5.15 |
| Tax Rate, % | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 | 47.9 |
| EBITAT | -270.9 | 25.7 | 15.6 | .2 | 44.0 | -47.5 | -52.5 | -57.9 | -64.0 | -70.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -345.2 | -10.3 | 19.0 | 27.7 | 90.6 | -3.2 | -38.5 | -42.5 | -46.9 | -51.8 |
| WACC, % | 12.64 | 12.74 | 12.74 | 10.25 | 11.32 | 11.94 | 11.94 | 11.94 | 11.94 | 11.94 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -123.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -53 | |||||||||
| Terminal Value | -532 | |||||||||
| Present Terminal Value | -303 | |||||||||
| Enterprise Value | -426 | |||||||||
| Net Debt | -392 | |||||||||
| Equity Value | -34 | |||||||||
| Diluted Shares Outstanding, MM | 392 | |||||||||
| Equity Value Per Share | -0.09 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real GDRX financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on GoodRx's valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life GDRX Financials: Pre-filled historical and projected data for GoodRx Holdings, Inc. (GDRX).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate GoodRx’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize GoodRx’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based GDRX DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates GoodRx's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator for GoodRx Holdings, Inc. (GDRX)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses all in one convenient package.
- Customizable Inputs: Modify the yellow-highlighted cells to explore various financial scenarios.
- Detailed Insights: Automatically computes the intrinsic value and Net Present Value for GoodRx Holdings, Inc. (GDRX).
- Preloaded Data: Access historical and forecasted data for accurate analysis starting points.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on GoodRx Holdings, Inc. (GDRX).
Who Should Use This Product?
- Investors: Accurately estimate GoodRx Holdings, Inc.’s (GDRX) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to GoodRx Holdings, Inc. (GDRX).
- Consultants: Quickly adapt the template for valuation reports tailored for GoodRx Holdings, Inc. (GDRX) clients.
- Entrepreneurs: Gain insights into financial modeling techniques utilized by leading companies like GoodRx Holdings, Inc. (GDRX).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies applicable to GoodRx Holdings, Inc. (GDRX).
What the Template Contains
- Historical Data: Includes GoodRx's past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate GoodRx's intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of GoodRx's financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.